Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 23.
Online ahead of print.

Encountering COVID-19 as Endocrinologists

Affiliations
  • PMID: 32372573
Free article
Review

Encountering COVID-19 as Endocrinologists

Eun Jung Rhee et al. Endocrinol Metab (Seoul). .
Free article

Abstract

The world is entering an era of disaster and chaos due to coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2. Since its first emergence in December 2019 in Wuhan, China, COVID-19 has swept through Asia and propagated throughout the world to Europe and North America. As of April 13, 1,773,084 people were infected and 111,652 people had died from COVID-19 globally, and new record levels of infection are being reported every day. Based on the data that have been amassed so far, the primary risk factors for a severe disease course or even mortality from COVID-19 are underlying diseases such as diabetes and hypertension. As the global prevalence of diabetes continues to increase, patients with endocrine diseases such as diabetes mellitus and those who are on long-term corticosteroid therapy due to adrenal insufficiency or hypopituitarism are at risk for a poor prognosis of COVID-19. As endocrinologists, we would like to briefly review the current knowledge about the relationship between COVID-19 and endocrine diseases and to discuss what we can do for the safety and health of our patients with endocrine diseases in this globally threatening situation.

Keywords: Adrenal insufficiency; COVID-19; Diabetes mellitus; Endocrine system diseases; Endocrinologists; Severe acute respiratory syndrome coronavirus 2.

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Similar articles

See all similar articles

LinkOut - more resources

Feedback